Craft

STRATEC

Stock Price

€37.3

2024-10-29

Market Capitalization

€455.2 M

2024-10-29

Revenue

€250.9 M

FY, 2025

STRATEC Summary

Company Summary

Overview
STRATEC is a provider of end-to-end automation solutions in the fields of in-vitro diagnostics and life sciences. It consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics, clinical chemistry and blood banking. In addition to replacement parts, maintenance kits and components consumed by instruments, the company offers complex consumables in which a part of the test processing is shifted from the analyzer system to the consumable itself.
Type
Public
Status
Active
Founded
1979
HQ
Birkenfeld, DE | view all locations
Website
https://www.stratec.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Marcus Wolfinger, Chairman, Board of Management

    • Frank Hiller, Deputy Chairman of Supervisory Board

      LocationsView all

      3 locations detected

      • Birkenfeld, Baden-Württemberg HQ

        Germany

        37 Gewerbestraße

      • Niederalm, Salzburg

        Austria

        Sonystraße 20

      • Yaizu, Shizuoka

        Japan

        Aikawa

      STRATEC Financials

      Summary Financials

      Revenue (Q1, 2026)
      €53.4M
      Gross profit (Q1, 2026)
      €16.3M
      Net income (Q1, 2026)
      (€1.7M)
      Cash (Q1, 2026)
      €23.7M
      EBIT (Q1, 2026)
      (€1.0K)
      Enterprise value
      $548.5M

      Footer menu